• Earlier this week, Rocket Lab confirmed it had secured a US$266 million firm-fixed-price contract from the U.S. Air Force and U.S. Space Force for 12 suborbital launches, with options for six additional missions through 2028 using its Electron and HASTE vehicles from the Pacific Spaceport Complex in Alaska.
• This long-term government launch award deepens Rocket Lab’s role in U.S. national security space programs and adds multi-year revenue visibility that can support capital-intensive projects such as the Neutron rocket and broader vertical integration.
• We’ll now examine how this multi-year US$266 million government launch contract could reshape Rocket Lab’s vertically integrated, defense-focused investment narrative.

Uncover the next big thing with 21 elite penny stocks that balance risk and reward.

Rocket Lab Investment Narrative Recap

To own Rocket Lab, you need to believe its vertically integrated space and defense platform can scale from small launch to profitable, multi-product national security partner, with Neutron as the key medium-lift unlock. This new US$266 million, firm-fixed-price government launch award supports that thesis by extending contracted revenue, but it does not remove the near term execution risk around Neutron’s development timeline and the company’s continued cash consumption.

Among recent updates, the planned US$8 billion acquisition of Iridium Communications stands out next to this launch contract. Together, they highlight how Rocket Lab is leaning into a defense-focused, end to end model that pairs launch, spacecraft, and now communications infrastructure. That could amplify both the upside of securing large, multi-year programs and the downside if integration, capital needs, or program delays weigh on results.

Yet behind the contract headlines, investors should also be aware that Neutron’s schedule and cash burn could...

Rocket Lab's narrative projects $1.8 billion revenue and $169.1 million earnings by 2029. This requires 37.6% yearly revenue growth and a $351.7 million earnings increase from -$182.6 million today.

Uncover how Rocket Lab's forecasts yield a $114.33 fair value, a 64% upside to its current price.

Exploring Other Perspectives

This new contract sits at the crossroads of two very different stories you might hear. The most optimistic analysts were already modeling revenue reaching about US$2.2 billion and earnings of roughly US$365 million by 2029, while also flagging heavy cash burn and dependence on big government awards. The Air Force deal could either support that upbeat view or force a rethink, so it is worth comparing these competing narratives before you decide how you feel about Rocket Lab’s trajectory.

Explore 35 other fair value estimates on Rocket Lab - why the stock might be worth less than half the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Rocket Lab research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Rocket Lab research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rocket Lab's overall financial health at a glance.

Searching For A Fresh Perspective?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 29 companies in the world exploring or producing it. Find the list for free.
• Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.